Insta
India Introduces Stricter Measures For Exporting Cough Syrups After Child Deaths In Gambia, Uzbekistan
Swarajya News Staff
May 23, 2023, 05:17 PM | Updated 05:17 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
After Indian-made cough syrups were linked to child deaths in Gambia and Uzbekistan, India will only allow cough syrup exports after government laboratory testing, according to a notice on Tuesday (23 May).
Starting from 1 June, in order to be exported, all cough syrups need a certificate of analysis from a government laboratory.
Cough syrups made in India are said to have caused 70 child deaths in Gambia and 19 in Uzbekistan, harming the reputation of India's $41 billion pharmaceutical industry.
India may alter its pharmaceutical industry policy, with plans to enhance cough syrup and raw materials testing, according to a recent Reuters report.
India exported cough syrups worth $17.6 billion in 2022-23, as against $17 billion in 2021-22.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.